PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-15.11%
Negative net income growth while CRWV stands at 7.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-17.00%
Negative yoy D&A while CRWV is 26.15%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
105.48%
Well above CRWV's 3.70% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-76.86%
Both cut yoy SBC, with CRWV at -21.18%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
586.33%
Slight usage while CRWV is negative at -110.52%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
169.42%
AR growth while CRWV is negative at -35.57%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.85%
Growth well above CRWV's 112.72%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-977.46%
Negative yoy while CRWV is 23.14%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
8.66%
Some CFO growth while CRWV is negative at -510.76%. John Neff would note a short-term liquidity lead over the competitor.
-23.84%
Both yoy lines negative, with CRWV at -74.30%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
12.50%
Purchases growth of 12.50% while CRWV is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-7.50%
Both yoy lines are negative, with CRWV at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
62.13%
We have mild expansions while CRWV is negative at -70.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
We repay more while CRWV is negative at -200.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
200.53%
Stock issuance far above CRWV's 4.88%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-120.27%
We cut yoy buybacks while CRWV is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.